<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33082139</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><Volume>295</Volume><Issue>52</Issue><PubDate><Year>2020</Year><Month>Dec</Month><Day>25</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>FUS contributes to mTOR-dependent inhibition of translation.</ArticleTitle><Pagination><StartPage>18459</StartPage><EndPage>18473</EndPage><MedlinePgn>18459-18473</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.RA120.013801</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0021-9258(17)50712-7</ELocationID><Abstract><AbstractText>The amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)-linked RNA-binding protein called FUS (<u>fu</u>sed in <u>s</u>arcoma) has been implicated in several aspects of RNA regulation, including mRNA translation. The mechanism by which FUS affects the translation of polyribosomes has not been established. Here we show that FUS can associate with stalled polyribosomes and that this association is sensitive to mTOR (mammalian target of rapamycin) kinase activity. Specifically, we show that FUS association with polyribosomes is increased by Torin1 treatment or when cells are cultured in nutrient-deficient media, but not when cells are treated with rapamycin, the allosteric inhibitor of mTORC1. Moreover, we report that FUS is necessary for efficient stalling of translation because deficient cells are refractory to the inhibition of mTOR-dependent signaling by Torin1. We also show that ALS-linked FUS mutants R521G and P525L associate abundantly with polyribosomes and decrease global protein synthesis. Importantly, the inhibitory effect on translation by FUS is impaired by mutations that reduce its RNA-binding affinity. These findings demonstrate that FUS is an important RNA-binding protein that mediates translational repression through mTOR-dependent signaling and that ALS-linked FUS mutants can cause a toxic gain of function in the cytoplasm by repressing the translation of mRNA at polyribosomes.</AbstractText><CopyrightInformation>&#xa9; 2020 S&#xe9;vigny et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>S&#xe9;vigny</LastName><ForeName>Myriam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Neuroscience, CERVO Brain Research Centre, Laval University, Quebec City, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bourdeau Julien</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Neuroscience, CERVO Brain Research Centre, Laval University, Quebec City, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venkatasubramani</LastName><ForeName>Janani Priya</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Neuroscience, CERVO Brain Research Centre, Laval University, Quebec City, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hui</LastName><ForeName>Jeremy B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Neuroscience, CERVO Brain Research Centre, Laval University, Quebec City, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dutchak</LastName><ForeName>Paul A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Neuroscience, CERVO Brain Research Centre, Laval University, Quebec City, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sephton</LastName><ForeName>Chantelle F</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Neuroscience, CERVO Brain Research Centre, Laval University, Quebec City, Quebec, Canada. Electronic address: chantelle.sephton.1@ulaval.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.1.1</RegistryNumber><NameOfSubstance UI="C546842">MTOR protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002479" MajorTopicYN="N">Inclusion Bodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011132" MajorTopicYN="N">Polyribosomes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014176" MajorTopicYN="N">Protein Biosynthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058570" MajorTopicYN="N">TOR Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RNA-binding protein</Keyword><Keyword MajorTopicYN="N">Torin1</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease)</Keyword><Keyword MajorTopicYN="N">fragile X mental retardation (FMRP)</Keyword><Keyword MajorTopicYN="N">frontotemporal degeneration (FTD)</Keyword><Keyword MajorTopicYN="N">fused in sarcoma (FUS)</Keyword><Keyword MajorTopicYN="N">mRNA translation</Keyword><Keyword MajorTopicYN="N">mTORC1</Keyword><Keyword MajorTopicYN="N">mTORC2</Keyword><Keyword MajorTopicYN="N">mammalian target of rapamycin (mTOR)</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">polyribosome</Keyword><Keyword MajorTopicYN="N">protein synthesis</Keyword><Keyword MajorTopicYN="N">rapamycin</Keyword><Keyword MajorTopicYN="N">ribosome</Keyword><Keyword MajorTopicYN="N">translation regulation</Keyword></KeywordList><CoiStatement>Conflict of interest&#x2014;The authors declare that they have no conflicts of interest with the contents of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>21</Day><Hour>5</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33082139</ArticleId><ArticleId IdType="pmc">PMC7939483</ArticleId><ArticleId IdType="doi">10.1074/jbc.RA120.013801</ArticleId><ArticleId IdType="pii">S0021-9258(17)50712-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lomen-Hoerth C., Anderson T., Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology. 2002;59:1077&#x2013;1079. doi: 10.1212/wnl.59.7.1077. 12370467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.59.7.1077</ArticleId><ArticleId IdType="pubmed">12370467</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Feldman H.H. Ubiquitin immunohistochemistry suggests classic motor neuron disease, motor neuron disease with dementia, and frontotemporal dementia of the motor neuron disease type represent a clinicopathologic spectrum. J. Neuropathol. Exp. Neurol. 2005;64:730&#x2013;739. doi: 10.1097/01.jnen.0000174335.27708.0a. 16106222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.jnen.0000174335.27708.0a</ArticleId><ArticleId IdType="pubmed">16106222</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipton A.M., White C.L., 3rd, Bigio E.H. Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration. Acta Neuropathol. 2004;108:379&#x2013;385. doi: 10.1007/s00401-004-0900-9. 15351890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-004-0900-9</ArticleId><ArticleId IdType="pubmed">15351890</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D., Haass C. Fused in sarcoma (FUS): an oncogene goes awry in neurodegeneration. Mol. Cell. Neurosci. 2013;56:475&#x2013;486. doi: 10.1016/j.mcn.2013.03.006. 23557964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2013.03.006</ArticleId><ArticleId IdType="pubmed">23557964</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortob&#xe1;gyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., Ganesalingam J., Williams K.L., Tripathi V., Al-Saraj S., Al-Chalabi A. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942. 19251628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Jr., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., Valdmanis P., Rouleau G.A., Hosler B.A., Cortelli P., de Jong P.J. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066. 19251627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Langenhove T., van der Zee J., Sleegers K., Engelborghs S., Vandenberghe R., Gijselinck I., Van den Broeck M., Mattheijssens M., Peeters K., De Deyn P.P., Cruts M., Van Broeckhoven C. Genetic contribution of FUS to frontotemporal lobar degeneration. Neurology. 2010;74:366&#x2013;371. doi: 10.1212/WNL.0b013e3181ccc732. 20124201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181ccc732</ArticleId><ArticleId IdType="pubmed">20124201</ArticleId></ArticleIdList></Reference><Reference><Citation>Huey E.D., Ferrari R., Moreno J.H., Jensen C., Morris C.M., Potocnik F., Kalaria R.N., Tierney M., Wassermann E.M., Hardy J., Grafman J., Momeni P. FUS and TDP43 genetic variability in FTD and CBS. Neurobiol. Aging. 2012;33:1016&#x2013;1017. doi: 10.1016/j.neurobiolaging.2011.08.004. 21943958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.08.004</ArticleId><ArticleId IdType="pmc">PMC4489700</ArticleId><ArticleId IdType="pubmed">21943958</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Rademakers R., Roeber S., Baker M., Kretzschmar H.A., Mackenzie I.R. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain. 2009;132:2922&#x2013;2931. doi: 10.1093/brain/awp214. 19674978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp214</ArticleId><ArticleId IdType="pmc">PMC2768659</ArticleId><ArticleId IdType="pubmed">19674978</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelaar H., Klijnsma K.Y., de Koning I., van der Lugt A., Chiu W.Z., Azmani A., Rozemuller A.J., van Swieten J.C. Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration. J. Neurol. 2010;257:747&#x2013;753. doi: 10.1007/s00415-009-5404-z. 19946779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-5404-z</ArticleId><ArticleId IdType="pmc">PMC2864899</ArticleId><ArticleId IdType="pubmed">19946779</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan A.Y., Manley J.L. The TET family of proteins: functions and roles in disease. J. Mol. Cell Biol. 2009;1:82&#x2013;92. doi: 10.1093/jmcb/mjp025. 19783543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjp025</ArticleId><ArticleId IdType="pmc">PMC2905059</ArticleId><ArticleId IdType="pubmed">19783543</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogelj B., Easton L.E., Bogu G.K., Stanton L.W., Rot G., Curk T., Zupan B., Sugimoto Y., Modic M., Haberman N., Tollervey J., Fujii R., Takumi T., Shaw C.E., Ule J. Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain. Sci. Rep. 2012;2:603. doi: 10.1038/srep00603. 22934129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep00603</ArticleId><ArticleId IdType="pmc">PMC3429604</ArticleId><ArticleId IdType="pubmed">22934129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishigaki S., Masuda A., Fujioka Y., Iguchi Y., Katsuno M., Shibata A., Urano F., Sobue G., Ohno K. Position-dependent FUS&#x2013;RNA interactions regulate alternative splicing events and transcriptions. Sci. Rep. 2012;2:529. doi: 10.1038/srep00529. 22829983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep00529</ArticleId><ArticleId IdType="pmc">PMC3402842</ArticleId><ArticleId IdType="pubmed">22829983</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoell J.I., Larsson E., Runge S., Nusbaum J.D., Duggimpudi S., Farazi T.A., Hafner M., Borkhardt A., Sander C., Tuschl T. RNA targets of wild-type and mutant FET family proteins. Nat. Struct. Mol. Biol. 2011;18:1428&#x2013;1431. doi: 10.1038/nsmb.2163. 22081015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2163</ArticleId><ArticleId IdType="pmc">PMC3230689</ArticleId><ArticleId IdType="pubmed">22081015</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M., Hutt K.R., Vu A.Q., Baughn M., Huelga S.C., Clutario K.M., Ling S.C., Liang T.Y., Mazur C., Wancewicz E., Kim A.S., Watt A., Freier S., Hicks G.G. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 2012;15:1488&#x2013;1497. doi: 10.1038/nn.3230. 23023293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3230</ArticleId><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrocola A.S., Kim S.H., Trinh A.T., Rodenkirch L.A., Tibbetts R.S. The RNA-binding protein fused in sarcoma (FUS) functions downstream of poly(ADP-ribose) polymerase (PARP) in response to DNA damage. J. Biol. Chem. 2013;288:24731&#x2013;24741. doi: 10.1074/jbc.M113.497974. 23833192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.497974</ArticleId><ArticleId IdType="pmc">PMC3750169</ArticleId><ArticleId IdType="pubmed">23833192</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz J.C., Ebmeier C.C., Podell E.R., Heimiller J., Taatjes D.J., Cech T.R. FUS binds the CTD of RNA polymerase II and regulates its phosphorylation at Ser2. Genes Dev. 2012;26:2690&#x2013;2695. doi: 10.1101/gad.204602.112. 23249733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.204602.112</ArticleId><ArticleId IdType="pmc">PMC3533074</ArticleId><ArticleId IdType="pubmed">23249733</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee B.J., Cansizoglu A.E., S&#xfc;el K.E., Louis T.H., Zhang Z., Chook Y.M. Rules for nuclear localization sequence recognition by karyopherin &#x3b2;2. Cell. 2006;126:543&#x2013;558. doi: 10.1016/j.cell.2006.05.049. 16901787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.05.049</ArticleId><ArticleId IdType="pmc">PMC3442361</ArticleId><ArticleId IdType="pubmed">16901787</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii R., Okabe S., Urushido T., Inoue K., Yoshimura A., Tachibana T., Nishikawa T., Hicks G.G., Takumi T. The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. Curr. Biol. 2005;15:587&#x2013;593. doi: 10.1016/j.cub.2005.01.058. 15797031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2005.01.058</ArticleId><ArticleId IdType="pubmed">15797031</ArticleId></ArticleIdList></Reference><Reference><Citation>Sephton C.F., Tang A.A., Kulkarni A., West J., Brooks M., Stubblefield J.J., Liu Y., Zhang M.Q., Green C.B., Huber K.M., Huang E.J., Herz J., Yu G. Activity-dependent FUS dysregulation disrupts synaptic homeostasis. Proc. Natl. Acad. Sci. U.S.A. 2014;111:E4769&#x2013;E4778. doi: 10.1073/pnas.1406162111. 25324524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1406162111</ArticleId><ArticleId IdType="pmc">PMC4226112</ArticleId><ArticleId IdType="pubmed">25324524</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K., Pratt G.A., Vu A.Q., Hutt K.R., Martinez F.J., Sundararaman B., Batra R., Freese P., Lambert N.J., Huelga S.C., Chun S.J., Liang T.Y., Chang J., Donohue J.P., Shiue L. Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses. Nat. Commun. 2016;7 doi: 10.1038/ncomms12143. 27378374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12143</ArticleId><ArticleId IdType="pmc">PMC4935974</ArticleId><ArticleId IdType="pubmed">27378374</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii R., Takumi T. TLS facilitates transport of mRNA encoding an actin-stabilizing protein to dendritic spines. J. Cell Sci. 2005;118:5755&#x2013;5765. doi: 10.1242/jcs.02692. 16317045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.02692</ArticleId><ArticleId IdType="pubmed">16317045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamelgarn M., Chen J., Kuang L., Jin H., Kasarskis E.J., Zhu H. ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay. Proc. Natl. Acad. Sci. U.S.A. 2018;115:E11904&#x2013;E11913. doi: 10.1073/pnas.1810413115. 30455313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1810413115</ArticleId><ArticleId IdType="pmc">PMC6304956</ArticleId><ArticleId IdType="pubmed">30455313</ArticleId></ArticleIdList></Reference><Reference><Citation>Udagawa T., Fujioka Y., Tanaka M., Honda D., Yokoi S., Riku Y., Ibi D., Nagai T., Yamada K., Watanabe H., Katsuno M., Inada T., Ohno K., Sokabe M., Okado H. FUS regulates AMPA receptor function and FTLD/ALS-associated behaviour via GluA1 mRNA stabilization. Nat. Commun. 2015;6 doi: 10.1038/ncomms8098. 25968143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms8098</ArticleId><ArticleId IdType="pmc">PMC4479014</ArticleId><ArticleId IdType="pubmed">25968143</ArticleId></ArticleIdList></Reference><Reference><Citation>Morlando M., Dini Modigliani S., Torrelli G., Rosa A., Di Carlo V., Caffarelli E., Bozzoni I. FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment. EMBO J. 2012;31:4502&#x2013;4510. doi: 10.1038/emboj.2012.319. 23232809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2012.319</ArticleId><ArticleId IdType="pmc">PMC3545295</ArticleId><ArticleId IdType="pubmed">23232809</ArticleId></ArticleIdList></Reference><Reference><Citation>Burd C.G., Dreyfuss G. Conserved structures and diversity of functions of RNA-binding proteins. Science. 1994;265:615&#x2013;621. doi: 10.1126/science.8036511. 8036511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8036511</ArticleId><ArticleId IdType="pubmed">8036511</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerga A., Hallier M., Delva L., Orvain C., Gallais I., Marie J., Moreau-Gachelin F. Identification of an RNA binding specificity for the potential splicing factor TLS. J. Biol. Chem. 2001;276:6807&#x2013;6816. doi: 10.1074/jbc.M008304200. 11098054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M008304200</ArticleId><ArticleId IdType="pubmed">11098054</ArticleId></ArticleIdList></Reference><Reference><Citation>Iko Y., Kodama T.S., Kasai N., Oyama T., Morita E.H., Muto T., Okumura M., Fujii R., Takumi T., Tate S., Morikawa K. Domain architectures and characterization of an RNA-binding protein, TLS. J. Biol. Chem. 2004;279:44834&#x2013;44840. doi: 10.1074/jbc.M408552200. 15299008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M408552200</ArticleId><ArticleId IdType="pubmed">15299008</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozdilek B.A., Thompson V.F., Ahmed N.S., White C.I., Batey R.T., Schwartz J.C. Intrinsically disordered RGG/RG domains mediate degenerate specificity in RNA binding. Nucleic Acids Res. 2017;45:7984&#x2013;7996. doi: 10.1093/nar/gkx460. 28575444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx460</ArticleId><ArticleId IdType="pmc">PMC5570134</ArticleId><ArticleId IdType="pubmed">28575444</ArticleId></ArticleIdList></Reference><Reference><Citation>Han T.W., Kato M., Xie S., Wu L.C., Mirzaei H., Pei J., Chen M., Xie Y., Allen J., Xiao G., McKnight S.L. Cell-free formation of RNA granules: bound RNAs identify features and components of cellular assemblies. Cell. 2012;149:768&#x2013;779. doi: 10.1016/j.cell.2012.04.016. 22579282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.04.016</ArticleId><ArticleId IdType="pubmed">22579282</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato M., Han T.W., Xie S., Shi K., Du X., Wu L.C., Mirzaei H., Goldsmith E.J., Longgood J., Pei J., Grishin N.V., Frantz D.E., Schneider J.W., Chen S., Li L. Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell. 2012;149:753&#x2013;767. doi: 10.1016/j.cell.2012.04.017. 22579281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.04.017</ArticleId><ArticleId IdType="pmc">PMC6347373</ArticleId><ArticleId IdType="pubmed">22579281</ArticleId></ArticleIdList></Reference><Reference><Citation>Murthy A.C., Dignon G.L., Kan Y., Zerze G.H., Parekh S.H., Mittal J., Fawzi N.L. Molecular interactions underlying liquid-liquid phase separation of the FUS low-complexity domain. Nat. Struct. Mol. Biol. 2019;26:637&#x2013;648. doi: 10.1038/s41594-019-0250-x. 31270472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-019-0250-x</ArticleId><ArticleId IdType="pmc">PMC6613800</ArticleId><ArticleId IdType="pubmed">31270472</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Erauskin J., Tadokoro T., Baughn M.W., Myers B., McAlonis-Downes M., Chillon-Marinas C., Asiaban J.N., Artates J., Bui A.T., Vetto A.P., Lee S.K., Le A.V., Sun Y., Jambeau M., Boubaker J. ALS/FTD-linked mutation in FUS suppresses intra-axonal protein synthesis and drives disease without nuclear loss-of-function of FUS. Neuron. 2018;100:816&#x2013;830.e7. doi: 10.1016/j.neuron.2018.09.044. 30344044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.09.044</ArticleId><ArticleId IdType="pmc">PMC6277851</ArticleId><ArticleId IdType="pubmed">30344044</ArticleId></ArticleIdList></Reference><Reference><Citation>Qamar S., Wang G., Randle S.J., Ruggeri F.S., Varela J.A., Lin J.Q., Phillips E.C., Miyashita A., Williams D., Strohl F., Meadows W., Ferry R., Dardov V.J., Tartaglia G.G., Farrer L.A. FUS phase separation is modulated by a molecular chaperone and methylation of arginine cation&#x2013;&#x3c0; interactions. Cell. 2018;173:720&#x2013;734.e15. doi: 10.1016/j.cell.2018.03.056. 29677515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.056</ArticleId><ArticleId IdType="pmc">PMC5927716</ArticleId><ArticleId IdType="pubmed">29677515</ArticleId></ArticleIdList></Reference><Reference><Citation>Jun M.H., Ryu H.H., Jun Y.W., Liu T., Li Y., Lim C.S., Lee Y.S., Kaang B.K., Jang D.J., Lee J.A. Sequestration of PRMT1 and Nd1-L mRNA into ALS-linked FUS mutant R521C-positive aggregates contributes to neurite degeneration upon oxidative stress. Sci. Rep. 2017;7 doi: 10.1038/srep40474. 28094300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep40474</ArticleId><ArticleId IdType="pmc">PMC5240339</ArticleId><ArticleId IdType="pubmed">28094300</ArticleId></ArticleIdList></Reference><Reference><Citation>Tischbein M., Baron D.M., Lin Y.C., Gall K.V., Landers J.E., Fallini C., Bosco D.A. The RNA-binding protein FUS/TLS undergoes calcium-mediated nuclear egress during excitotoxic stress and is required for GRIA2 mRNA processing. J. Biol. Chem. 2019;294:10194&#x2013;10210. doi: 10.1074/jbc.RA118.005933. 31092554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.005933</ArticleId><ArticleId IdType="pmc">PMC6664169</ArticleId><ArticleId IdType="pubmed">31092554</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Scotter E.L., Nishimura A.L., Troakes C., Mitchell J.C., Kathe C., Urwin H., Manser C., Miller C.C., Hortob&#xe1;gyi T., Dragunow M., Rogelj B., Shaw C.E. ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules. Hum. Mol. Genet. 2013;22:2676&#x2013;2688. doi: 10.1093/hmg/ddt117. 23474818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt117</ArticleId><ArticleId IdType="pmc">PMC3674807</ArticleId><ArticleId IdType="pubmed">23474818</ArticleId></ArticleIdList></Reference><Reference><Citation>Groen E.J., Fumoto K., Blokhuis A.M., Engelen-Lee J., Zhou Y., van den Heuvel D.M., Koppers M., van Diggelen F., van Heest J., Demmers J.A., Kirby J., Shaw P.J., Aronica E., Spliet W.G., Veldink J.H. ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN. Hum. Mol. Genet. 2013;22:3690&#x2013;3704. doi: 10.1093/hmg/ddt222. 23681068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt222</ArticleId><ArticleId IdType="pubmed">23681068</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamelgarn M., Chen J., Kuang L., Arenas A., Zhai J., Zhu H., Gal J. Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS. Biochim. Biophys. Acta. 2016;1862:2004&#x2013;2014. doi: 10.1016/j.bbadis.2016.07.015. 27460707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2016.07.015</ArticleId><ArticleId IdType="pmc">PMC5055831</ArticleId><ArticleId IdType="pubmed">27460707</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuda K., Zhang H., Loiselle D., Haystead T., Macara I.G., Mili S. The RNA-binding protein Fus directs translation of localized mRNAs in APC-RNP granules. J. Cell Biol. 2013;203:737&#x2013;746. doi: 10.1083/jcb.201306058. 24297750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201306058</ArticleId><ArticleId IdType="pmc">PMC3857475</ArticleId><ArticleId IdType="pubmed">24297750</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelkovnikova T.A., Robinson H.K., Southcombe J.A., Ninkina N., Buchman V.L. Multistep process of FUS aggregation in the cell cytoplasm involves RNA-dependent and RNA-independent mechanisms. Hum. Mol. Genet. 2014;23:5211&#x2013;5226. doi: 10.1093/hmg/ddu243. 24842888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu243</ArticleId><ArticleId IdType="pmc">PMC4159159</ArticleId><ArticleId IdType="pubmed">24842888</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A., Lee H.O., Jawerth L., Maharana S., Jahnel M., Hein M.Y., Stoynov S., Mahamid J., Saha S., Franzmann T.M., Pozniakovski A., Poser I., Maghelli N., Royer L.A., Weigert M. A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell. 2015;162:1066&#x2013;1077. doi: 10.1016/j.cell.2015.07.047. 26317470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.07.047</ArticleId><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson P., Kedersha N. Stress granules: the Tao of RNA triage. Trends Biochem. Sci. 2008;33:141&#x2013;150. doi: 10.1016/j.tibs.2007.12.003. 18291657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2007.12.003</ArticleId><ArticleId IdType="pubmed">18291657</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D., Madl T., Valori C.F., Bentmann E., Tahirovic S., Abou-Ajram C., Kremmer E., Ansorge O., Mackenzie I.R., Neumann M., Haass C. Arginine methylation next to the PY-NLS modulates transportin binding and nuclear import of FUS. EMBO J. 2012;31:4258&#x2013;4275. doi: 10.1038/emboj.2012.261. 22968170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2012.261</ArticleId><ArticleId IdType="pmc">PMC3501225</ArticleId><ArticleId IdType="pubmed">22968170</ArticleId></ArticleIdList></Reference><Reference><Citation>Tradewell M.L., Yu Z., Tibshirani M., Boulanger M.C., Durham H.D., Richard S. Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS/TLS harbouring ALS-linked mutations. Hum. Mol. Genet. 2012;21:136&#x2013;149. doi: 10.1093/hmg/ddr448. 21965298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr448</ArticleId><ArticleId IdType="pubmed">21965298</ArticleId></ArticleIdList></Reference><Reference><Citation>Darovic S., Prpar Mihevc S., Zupunski V., Guncar G., Stalekar M., Lee Y.B., Shaw C.E., Rogelj B. Phosphorylation of C-terminal tyrosine residue 526 in FUS impairs its nuclear import. J. Cell Sci. 2015;128:4151&#x2013;4159. doi: 10.1242/jcs.176602. 26403203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.176602</ArticleId><ArticleId IdType="pubmed">26403203</ArticleId></ArticleIdList></Reference><Reference><Citation>Monahan Z., Ryan V.H., Janke A.M., Burke K.A., Rhoads S.N., Zerze G.H., O'Meally R., Dignon G.L., Conicella A.E., Zheng W., Best R.B., Cole R.N., Mittal J., Shewmaker F., Fawzi N.L. Phosphorylation of the FUS low-complexity domain disrupts phase separation, aggregation, and toxicity. EMBO J. 2017;36:2951&#x2013;2967. doi: 10.15252/embj.201696394. 28790177.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201696394</ArticleId><ArticleId IdType="pmc">PMC5641905</ArticleId><ArticleId IdType="pubmed">28790177</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G.Y., Sabatini D.M. mTOR at the nexus of nutrition, growth, ageing and disease. Nat. Rev. Mol. Cell Biol. 2020;21:183&#x2013;203. doi: 10.1038/s41583-020-0269-3. doi: 10.1038/s41580-019-0199-y. 31937935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-020-0269-3</ArticleId><ArticleId IdType="doi">10.1038/s41580-019-0199-y</ArticleId><ArticleId IdType="pmc">PMC7102936</ArticleId><ArticleId IdType="pubmed">31937935</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Guan K.L. mTOR as a central hub of nutrient signalling and cell growth. Nat. Cell Biol. 2019;21:63&#x2013;71. doi: 10.1038/s41556-018-0205-1. 30602761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-018-0205-1</ArticleId><ArticleId IdType="pubmed">30602761</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourdeau Julien I., Sephton C.F., Dutchak P.A. Metabolic networks influencing skeletal muscle fiber composition. Front. Cell Dev. Biol. 2018;6:125. doi: 10.3389/fcell.2018.00125. 30324104.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2018.00125</ArticleId><ArticleId IdType="pmc">PMC6172607</ArticleId><ArticleId IdType="pubmed">30324104</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutchak P.A., Estill-Terpack S.J., Plec A.A., Zhao X., Yang C., Chen J., Ko B., Deberardinis R.J., Yu Y., Tu B.P. Loss of a negative regulator of mTORC1 induces aerobic glycolysis and altered fiber composition in skeletal muscle. Cell Rep. 2018;23:1907&#x2013;1914. doi: 10.1016/j.celrep.2018.04.058. 29768191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.04.058</ArticleId><ArticleId IdType="pmc">PMC6038807</ArticleId><ArticleId IdType="pubmed">29768191</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung J., Kuo C.J., Crabtree G.R., Blenis J. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell. 1992;69:1227&#x2013;1236. doi: 10.1016/0092-8674(92)90643-Q. 1377606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(92)90643-Q</ArticleId><ArticleId IdType="pubmed">1377606</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauvin C., Koka V., Nouschi A., Mieulet V., Hoareau-Aveilla C., Dreazen A., Cagnard N., Carpentier W., Kiss T., Meyuhas O., Pende M. Ribosomal protein S6 kinase activity controls the ribosome biogenesis transcriptional program. Oncogene. 2014;33:474&#x2013;483. doi: 10.1038/onc.2012.606. 23318442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2012.606</ArticleId><ArticleId IdType="pubmed">23318442</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalsky A.H., Namkoong S., Mettetal E., Park H.W., Kazyken D., Fingar D.C., Lee J.H. The GATOR2-mTORC2 axis mediates Sestrin2-induced AKT Ser/Thr kinase activation. J. Biol. Chem. 2020;295:1769&#x2013;1780. doi: 10.1074/jbc.RA119.010857. 31915252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA119.010857</ArticleId><ArticleId IdType="pmc">PMC7029113</ArticleId><ArticleId IdType="pubmed">31915252</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore S.F., Hunter R.W., Hers I. mTORC2 protein complex&#x2013;mediated Akt (protein kinase B) serine 473 phosphorylation is not required for Akt1 activity in human platelets [corrected] J. Biol. Chem. 2011;286:24553&#x2013;24560. doi: 10.1074/jbc.M110.202341. 21592956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.202341</ArticleId><ArticleId IdType="pmc">PMC3137030</ArticleId><ArticleId IdType="pubmed">21592956</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang I.F., Guo B.S., Liu Y.C., Wu C.C., Yang C.H., Tsai K.J., Shen C.K. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc. Natl. Acad. Sci. U.S.A. 2012;109:15024&#x2013;15029. doi: 10.1073/pnas.1206362109. 22932872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1206362109</ArticleId><ArticleId IdType="pmc">PMC3443184</ArticleId><ArticleId IdType="pubmed">22932872</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Li L., Chen S., Yang D., Wang Y., Zhang X., Wang Z., Le W. Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Autophagy. 2011;7:412&#x2013;425. doi: 10.4161/auto.7.4.14541. 21193837.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.7.4.14541</ArticleId><ArticleId IdType="pubmed">21193837</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Z., Sheehan P., Chen S., Yue Z. Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease? Mol. Neurodegener. 2017;12:90. doi: 10.1186/s13024-017-0232-6. 29282133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0232-6</ArticleId><ArticleId IdType="pmc">PMC5746010</ArticleId><ArticleId IdType="pubmed">29282133</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan R.D., Arnstein H.R. The dissociation of rabbit reticulocyte ribosomes with EDTA and the location of messenger ribonucleic acid. Eur. J. Biochem. 1969;9:445&#x2013;450. doi: 10.1111/j.1432-1033.1969.tb00629.x. 4979901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1432-1033.1969.tb00629.x</ArticleId><ArticleId IdType="pubmed">4979901</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcus L., Ris H., Halvorson H.O., Bretthauer R.K., Bock R.M. Occurrence, isolation, and characterization of polyribosomes in yeast. J. Cell Biol. 1967;34:505&#x2013;512. doi: 10.1083/jcb.34.2.505. 6035641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.34.2.505</ArticleId><ArticleId IdType="pmc">PMC2107312</ArticleId><ArticleId IdType="pubmed">6035641</ArticleId></ArticleIdList></Reference><Reference><Citation>He Q., Ge W. The tandem Agenet domain of fragile X mental retardation protein interacts with FUS. Sci. Rep. 2017;7:962. doi: 10.1038/s41598-017-01175-8. 28424484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-01175-8</ArticleId><ArticleId IdType="pmc">PMC5430443</ArticleId><ArticleId IdType="pubmed">28424484</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefani G., Fraser C.E., Darnell J.C., Darnell R.B. Fragile X mental retardation protein is associated with translating polyribosomes in neuronal cells. J. Neurosci. 2004;24:7272&#x2013;7276. doi: 10.1523/JNEUROSCI.2306-04.2004. 15317853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2306-04.2004</ArticleId><ArticleId IdType="pmc">PMC6729764</ArticleId><ArticleId IdType="pubmed">15317853</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbin F., Bouillon M., Fortin A., Morin S., Rousseau F., Khandjian E.W. The fragile X mental retardation protein is associated with poly(A)+ mRNA in actively translating polyribosomes. Hum. Mol. Genet. 1997;6:1465&#x2013;1472. doi: 10.1093/hmg/6.9.1465. 9285783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/6.9.1465</ArticleId><ArticleId IdType="pubmed">9285783</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Y., Absher D., Eberhart D.E., Brown V., Malter H.E., Warren S.T. FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol. Cell. 1997;1:109&#x2013;118. doi: 10.1016/S1097-2765(00)80012-X. 9659908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(00)80012-X</ArticleId><ArticleId IdType="pubmed">9659908</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxton R.A., Sabatini D.M. mTOR signaling in growth, metabolism, and disease. Cell. 2017;169:361&#x2013;371. doi: 10.1016/j.cell.2017.03.035. 28388417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.03.035</ArticleId><ArticleId IdType="pubmed">28388417</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutchak P.A., Laxman S., Estill S.J., Wang C., Wang Y., Wang Y., Bulut G.B., Gao J., Huang L.J., Tu B.P. Regulation of hematopoiesis and methionine homeostasis by mTORC1 inhibitor NPRL2. Cell Rep. 2015;12:371&#x2013;379. doi: 10.1016/j.celrep.2015.06.042. 26166573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.06.042</ArticleId><ArticleId IdType="pmc">PMC4830278</ArticleId><ArticleId IdType="pubmed">26166573</ArticleId></ArticleIdList></Reference><Reference><Citation>Biever A., Glock C., Tushev G., Ciirdaeva E., Dalmay T., Langer J.D., Schuman E.M. Monosomes actively translate synaptic mRNAs in neuronal processes. Science. 2020;367 doi: 10.1126/science.aay4991. 32001627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aay4991</ArticleId><ArticleId IdType="pubmed">32001627</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyer E.E., Moore M.J. Redefining the translational status of 80S monosomes. Cell. 2016;164:757&#x2013;769. doi: 10.1016/j.cell.2016.01.003. 26871635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.01.003</ArticleId><ArticleId IdType="pubmed">26871635</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshikawa H., Larance M., Harney D.J., Sundaramoorthy R., Ly T., Owen-Hughes T., Lamond A.I. Efficient analysis of mammalian polysomes in cells and tissues using Ribo mega-SEC. eLife. 2018;7 doi: 10.7554/eLife.36530. 30095066.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.36530</ArticleId><ArticleId IdType="pmc">PMC6086667</ArticleId><ArticleId IdType="pubmed">30095066</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Q., Holler C.J., Taylor G., Hudson K.F., Watkins W., Gearing M., Ito D., Murray M.E., Dickson D.W., Seyfried N.T., Kukar T. FUS is phosphorylated by DNA-PK and accumulates in the cytoplasm after DNA damage. J. Neurosci. 2014;34:7802&#x2013;7813. doi: 10.1523/JNEUROSCI.0172-14.2014. 24899704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0172-14.2014</ArticleId><ArticleId IdType="pmc">PMC4044245</ArticleId><ArticleId IdType="pubmed">24899704</ArticleId></ArticleIdList></Reference><Reference><Citation>Thoreen C.C., Chantranupong L., Keys H.R., Wang T., Gray N.S., Sabatini D.M. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature. 2012;485:109&#x2013;113. doi: 10.1038/nature11083. 22552098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11083</ArticleId><ArticleId IdType="pmc">PMC3347774</ArticleId><ArticleId IdType="pubmed">22552098</ArticleId></ArticleIdList></Reference><Reference><Citation>Sephton C.F., Yu G. The function of RNA-binding proteins at the synapse: implications for neurodegeneration. Cell. Mol. Life Sci. 2015;72:3621&#x2013;3635. doi: 10.1007/s00018-015-1943-x. 26047658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-015-1943-x</ArticleId><ArticleId IdType="pmc">PMC4565867</ArticleId><ArticleId IdType="pubmed">26047658</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacinto E., Loewith R., Schmidt A., Lin S., Ruegg M.A., Hall A., Hall M.N. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 2004;6:1122&#x2013;1128. doi: 10.1038/ncb1183. 15467718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1183</ArticleId><ArticleId IdType="pubmed">15467718</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal R., Palmieri M., Chaudhury A., Klisch T.J., di Ronza A., Neilson J.R., Rodney G.G., Sardiello M. Src regulates amino acid&#x2013;mediated mTORC1 activation by disrupting GATOR1&#x2013;Rag GTPase interaction. Nat. Commun. 2018;9 doi: 10.1038/s41467-018-06844-4. 30341294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06844-4</ArticleId><ArticleId IdType="pmc">PMC6195609</ArticleId><ArticleId IdType="pubmed">30341294</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogaert E., Boeynaems S., Kato M., Guo L., Caulfield T.R., Steyaert J., Scheveneels W., Wilmans N., Haeck W., Hersmus N., Schymkowitz J., Rousseau F., Shorter J., Callaerts P., Robberecht W. Molecular dissection of FUS points at synergistic effect of low-complexity domains in toxicity. Cell Rep. 2018;24:529&#x2013;537.e4. doi: 10.1016/j.celrep.2018.06.070. 30021151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.06.070</ArticleId><ArticleId IdType="pmc">PMC6077250</ArticleId><ArticleId IdType="pubmed">30021151</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J., D'Amico R., Zucchi E., Gessani A., Fini N., Fasano A., Caponnetto C., Chio A., Dalla Bella E., Lunetta C., Mazzini L., Marinou K., Soraru G., de Biasi S., Lo Tartaro D. Rapamycin treatment for amyotrophic lateral sclerosis: protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) Medicine. 2018;97 doi: 10.1097/MD.0000000000011119. 29901635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000011119</ArticleId><ArticleId IdType="pmc">PMC6024184</ArticleId><ArticleId IdType="pubmed">29901635</ArticleId></ArticleIdList></Reference><Reference><Citation>Imperatore J.A., McAninch D.S., Valdez-Sinon A.N., Bassell G.J., Mihailescu M.R. FUS recognizes G quadruplex structures within neuronal mRNAs. Front. Mol. Biosci. 2020;7:6. doi: 10.3389/fmolb.2020.00006. 32118033.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2020.00006</ArticleId><ArticleId IdType="pmc">PMC7018707</ArticleId><ArticleId IdType="pubmed">32118033</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanan U., Nalavadi V., Nakamoto M., Thomas G., Ceman S., Bassell G.J., Warren S.T. S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade. J. Biol. Chem. 2008;283:18478&#x2013;18482. doi: 10.1074/jbc.C800055200. 18474609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C800055200</ArticleId><ArticleId IdType="pmc">PMC2441545</ArticleId><ArticleId IdType="pubmed">18474609</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalavadi V.C., Muddashetty R.S., Gross C., Bassell G.J. Dephosphorylation-induced ubiquitination and degradation of FMRP in dendrites: a role in immediate early mGluR-stimulated translation. J. Neurosci. 2012;32:2582&#x2013;2587. doi: 10.1523/JNEUROSCI.5057-11.2012. 22357842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5057-11.2012</ArticleId><ArticleId IdType="pmc">PMC3427762</ArticleId><ArticleId IdType="pubmed">22357842</ArticleId></ArticleIdList></Reference><Reference><Citation>Das Sharma S., Metz J.B., Li H., Hobson B.D., Hornstein N., Sulzer D., Tang G., Sims P.A. Widespread alterations in translation elongation in the brain of juvenile Fmr1 knockout mice. Cell Rep. 2019;26:3313&#x2013;3322.e5. doi: 10.1016/j.celrep.2019.02.086. 30893603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.02.086</ArticleId><ArticleId IdType="pmc">PMC6457272</ArticleId><ArticleId IdType="pubmed">30893603</ArticleId></ArticleIdList></Reference><Reference><Citation>De Rubeis S., Pasciuto E., Li K.W., Fern&#xe1;ndez E., Di Marino D., Buzzi A., Ostroff L.E., Klann E., Zwartkruis F.J., Komiyama N.H., Grant S.G., Poujol C., Choquet D., Achsel T., Posthuma D. CYFIP1 coordinates mRNA translation and cytoskeleton remodeling to ensure proper dendritic spine formation. Neuron. 2013;79:1169&#x2013;1182. doi: 10.1016/j.neuron.2013.06.039. 24050404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.06.039</ArticleId><ArticleId IdType="pmc">PMC3781321</ArticleId><ArticleId IdType="pubmed">24050404</ArticleId></ArticleIdList></Reference><Reference><Citation>Sephton C.F., Cenik C., Kucukural A., Dammer E.B., Cenik B., Han Y., Dewey C.M., Roth F.P., Herz J., Peng J., Moore M.J., Yu G. Identification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexes. J. Biol. Chem. 2011;286:1204&#x2013;1215. doi: 10.1074/jbc.M110.190884. 21051541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.190884</ArticleId><ArticleId IdType="pmc">PMC3020728</ArticleId><ArticleId IdType="pubmed">21051541</ArticleId></ArticleIdList></Reference><Reference><Citation>Sephton C.F., Good S.K., Atkin S., Dewey C.M., Mayer P., 3rd, Herz J., Yu G. TDP-43 is a developmentally regulated protein essential for early embryonic development. J. Biol. Chem. 2010;285:6826&#x2013;6834. doi: 10.1074/jbc.M109.061846. 20040602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.061846</ArticleId><ArticleId IdType="pmc">PMC2825476</ArticleId><ArticleId IdType="pubmed">20040602</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>